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Abstract
Peripheral artery disease (PAD) is a condition caused by atherosclerotic block-
ages in the arteries supplying the lower limbs and is characterized by ischemia
of the leg, progressive myopathy, and increased risk of limb loss. The affected
leg muscles undergo significant changes of their biochemistry and metabolism
including variations in the levels of many key proteins, lipids, and nucleotides.
The mechanisms behind these changes are poorly understood. The objective
of this study was to correlate the severity of the PAD disease stage and associ-
ated hemodynamic limitation (determined by the ankle brachial index, ABI)
in the legs of the patients with alterations in the biochemistry of chronically
ischemic leg muscle as determined by ATR-Fourier transform infrared micro-
spectroscopy. Muscle (gastrocnemius) biopsies were collected from 13 subjects
including four control patients (ABI≥0.9), five claudicating patients
(0.4 ≤ ABI<0.9), and four critical limb ischemia (CLI) patients (ABI<0.4).
Slide mounted specimens were analyzed by ATR-Fourier transform infrared
micro-spectroscopy. An analysis of variance and a partial least squares regres-
sion model were used to identify significant differences in spectral peaks and
correlate them with the ABI. The spectra revealed significant differences
(P < 0.05) across control, claudicating, and CLI patients in the fingerprint
and functional group regions. Infrared microspectroscopic probing of ischemic
muscle biopsies demonstrates that PAD produces significant and unique
changes to muscle biochemistry in comparison to control specimens. These
distinctive biochemical profiles correlate with disease progression and may
provide insight and direction for new targets in the diagnosis and therapy of
muscle degeneration in PAD.
Introduction
Peripheral artery disease (PAD) is a consequence of
reduced blood flow caused by atherosclerotic plaque
buildup, (Schirmang et al. 2009) causing stenosis and
obstruction in the arteries supplying the lower limbs (Flu
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et al. 2010). The most common and early presenting
symptom of PAD is claudication, which is usually identi-
fied by muscle discomfort, fatigue or pain in the legs after
walking a short distance (Schirmang et al. 2009). If the
disease continues to progress, blood flow to the extremi-
ties continues to decrease, causing critical limb ischemia
(CLI), a condition characterized by chronic ischemic pain
at rest and tissue loss (nonhealing ulcers or gangrene). At
this stage of the disease, the prognosis of the limb is poor,
with half of patients presenting with CLI requiring limb
amputation within 1 year from their presentation (Fein-
glass et al. 1999; Norgren et al. 2007; Ziegler-Graham
et al. 2008). Metabolic demands of the ischemic tissue,
the location of the affected artery, and the degree of the
myopathy in the leg muscles are all key factors that influ-
ence the severity of PAD symptoms (Pipinos et al. 2007,
2008; Hills et al. 2009).
Currently the ankle-brachial index (ABI), a simple non-
invasive technique for detecting arterial obstructions, is
used as the standard test for PAD diagnosis (McLafferty
et al. 1997). Arterial blockages are identified by dividing
the systolic blood pressure at each ankle by the systolic
blood pressure at the arm, and the ratio of these values is
used to determine the degree of restriction of blood flow
through the lower extremities (McLafferty et al. 1997).
Other noninvasive diagnostic tests include pulse volume
recordings, toe brachial index, and transcutaneous oxygen
measurement (McLafferty et al. 1997). However, none of
these tests measure the effects that reduced blood flow
has on the end organ and the damage to the skeletal mus-
cle. At the histological level, progressive skeletal muscle
damage causes structural abnormalities in the myofibers,
as well as intracellular-extracellular histological and bio-
chemical changes (Busch et al. 1972; Cullen and
Fulthorpe 1975; Cluff et al. 2013). These changes indicate
damage at a level which cannot be measured by the ABI
and its related tests (Maunder et al. 1977).
Recently, optical probing methods, such as Raman
spectroscopy, Fourier Transform Infrared (FTIR) spec-
troscopy, and hyperspectral imaging have shown promise
toward providing important molecular information for
the analysis of diseases. These techniques are novel
because they utilize label-free methods to obtain informa-
tion-rich biochemical spectral signatures of diseased tis-
sues, providing insight into the disease progression that
cannot be identified through traditional histological anal-
ysis. Prior work from our group has shown that Raman
spectroscopy can identify key changes in spectral peaks
which correlate with hemodynamic limitation (ABI) in
PAD patients (Cluff et al. 2014). Fourier transform infra-
red (FTIR) spectroscopy is an analytical technique that
measures changes in molecular vibrations within a tissue
sample, and is a powerful tool that can be used to
characterize the biochemical profile at the cellular level
for many pathologies (Wood et al. 1996; Wang et al.
1997; Eckel et al. 2001; Fujioka et al. 2004; Baker et al.
2008). Further, it is considered complimentary to Raman
spectroscopy, providing information from infrared (IR)
active peaks that would otherwise be Raman inactive. IR
spectral signals tend to obtain stronger signals for asym-
metric polar bonds, whereas Raman signals are stronger
for symmetric, nonpolar bonds (Ali et al. 2013). These
techniques have been used to analyze various disease
states and can distinguish subcellular structures and bio-
chemical makeup in affected tissues (Krafft et al. 2008). It
has been used as a tool for investigating changes in bio-
chemical constituents (e.g., protein content, lipids, carbo-
hydrates, and nucleic acids) (Palaniappan and Pramod
2010) and in differentiating between healthy and diseased
tissues (Cheng et al. 2004), and has proven efficacy in
toxicological studies (Sivakumar et al. 2014). FTIR has
also been used to detect spectral differences between nor-
mal and cancerous tissues of the gastrointestinal tract
(stomach, colon, and esophagus) (Peng et al. 1998), and
has emerged as a useful and accurate tool for the determi-
nation of the secondary structure of proteins (Susi and
Byler 1986; Surewicz et al. 1993). Attenuated total reflec-
tance (ATR) is a type of FTIR technique that utilizes the
properties of evanescent waves to obtain spectra, rather
than the transmission method seen in traditional IR spec-
troscopy, and has been shown in studies to produce high-
quality meaningful spectra to characterize cell and tissue
samples (Wong et al. 1995; Andrew Chan and Kazarian
2016).
The objective of this study was to correlate the hemo-
dynamic limitation in the legs of PAD patients, with
alterations in the biochemistry of their chronically
ischemic leg muscle as determined by ATR-FTIR micro-
spectroscopy. Our central hypothesis was that broad
reaching spectroscopic probing of the ischemic muscle
may reveal or identify significant changes to the muscle
biochemistry that may be used into identify potential
mechanisms of PAD myopathy. The rationale that under-
lies this research is that spectroscopic techniques provide
information-rich spectral signatures of the biochemistry
of the evaluated tissue specimens that is not limited to
one or two targets at a time, as is in standard histopatho-
logical analyses.
Materials and Methods
Tissue samples
The tissue sample collection protocol was approved by
the Institutional Review Board of the VA Nebraska-
Western Iowa and University of Nebraska Medical
2017 | Vol. 5 | Iss. 5 | e13161
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Centers and all subjects gave informed consent. We col-
lected biopsies from the gastrocnemius of four patients
with clinically diagnosed critical limb ischemia (CLI)
(ABI<0.4), five patients with clinically diagnosed claudica-
tion (and 0.4 ≤ ABI<0.9), and four control patients (pa-
tients with no lower limb impairment or symptoms of
PAD and a resting ABI≥0.9) (Schirmang et al. 2009).
Muscle biopsies were collected with a 6 mm Bergstrom
needle from the anteromedial aspect of the gastrocnemius,
approximately 10 cm distal to the tibial tuberosity. The
biopsies were fixed in methacarn and embedded in paraf-
fin. The muscle samples were cut at 4 lm in cross-section
and mounted on slides for spectral analysis. Demographic
data from these patients are given in Table 1.
ATR-FTIR Micro-spectroscopy data collection
ATR-FTIR micro-spectroscopy was used to analyze PAD
muscle tissue and establish a framework for a new
methodology to identify potential mechanisms of the
myopathy. Prior to spectral data collection, the muscle
sample slides were deparaffinized with xylene, dehydrated
through a series of ethanol washes, and allowed to air
dry. Microspectral signatures were collected on a high-
performance FTIR microscope (Smiths IlluminatIR™
SensIR) equipped with a microspectroscopy ATR 159
objective accessory with a diamond tip of 100 lm in
diameter. ATR-FTIR microspectral signatures were col-
lected from the fingerprint and functional group regions
(600–4000 cm1). A background correction spectrum was
collected before each specimen spectrum, 128 scans were
collected and averaged to provide a high signal-to-noise
ratio, and the spectral resolution was set to 4 cm1.
Microspectroscopy allowed spectral data collection
from specific locations inside the muscle tissue samples.
Microspectral signatures were collected from the center of
10 representative myofibers from each specimen resulting
in a total of 130 microspectral signatures. Myofibers were
selected based on a visual inspection of myofiber mor-
phology and myopathic characteristics, such as abnormal
fiber area, irregular diameter, roundness, fiber density,
and clustering of irregular-shaped myofibers. Figure 1A–C
displays abnormal PAD muscle morphology in contrast to
healthy muscle shape features (Cluff et al. 2013). In our
previous studies, these myofiber morphometrics were
objectively defined, correlated with clinical stages of PAD,
associated with limb dysfunction, and characterized
advancing PAD muscle degeneration (Cluff et al. 2013;
Koutakis et al., 2015b). The panels in Figure 1 present
myosin labeled images overlaid with myofiber outlines,
sarcolemma labeled images overlaid with myofiber outli-
nes, and binary images of the myofiber segmentations.
Data preprocessing
Data preprocessing included baseline correction, smooth-
ing, and normalization of the raw ATR-FTIR microspec-
tral signatures. Baseline correction and smoothing were
performed to remove additive noise and are essential
steps in spectral biosignal processing (Chen et al. 2004;
Sweeney et al. 2012; Cluff et al. 2016). The spectral data
were smoothed using a 15-point box-car smoothing algo-
rithm. A baseline correction algorithm was developed in
Matlab software (R2015b, The Mathworks Inc., MA) to
iteratively optimize a piecewise cubic interpolation of the
raw ATR-FTIR spectra.
Normalization was done in order to remove multiplica-
tive error and put the data on the same scale to allow
comparisons of the results and relationships among spec-
tra. Although there are several approaches to normalizing
spectral data, two common methods are multiplicative
scatter correction (MSC) and standard normal variate
(SNV) normalization (Rinnan 2009; Azzalini et al. 2012).
We normalized the ATR-FTIR spectra using the standard
normal variate (SNV) technique because it is designed to
remove multiplicative error and preserve the linear rela-
tionship between the spectral signal and sample concen-
tration (Barnes et al. 1989; Rinnan 2009).
Data analysis
Standard univariate statistical analysis of variance
(ANOVA) followed by a Bonferroni adjusted multiple
comparison analysis was performed on four prominent
regions in the spectra to assess if there were statistically
significant differences in the spectral profiles. The signifi-
cance level was set as a = 0.05. Additionally, a multivari-
ate partial least squares regression (PLSR) model was
Table 1. Demographics of patients with peripheral artery disease
and control patients.
Control Claudication CLI1
Number of subjects 4 5 4
Mean Age
(years)  Std.
deviation
59  7.8 62.8  3.7 59  6.3
Ankle brachial
index (ABI)
1.07  0.05 0.6  0.10 0.22  0.09
Sex (male/female) 3/1 5/0 4/0
Obesity 50% 80% 25%
Hypertension 75% 100% 100%
Diabetes mellitus 50% 80% 50%
Smoking 25% 60% 25%
1
Critical Limb Ischemia.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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developed using the entire spectral region (600 cm1 to
4000 cm1) to predict patient ABI’s. The PLSR algorithm
combines techniques used in principal component analy-
sis and multiple linear regression and attempts to quantify
the strength of the relationship between the response vari-
able and a set of predictor variables (Geladi and Kowalski
1986). PLSR searches for principal components (called
factors) that are orthogonal to each other (i.e., indepen-
dent) and tries to relate them to the response variable.
The variation present in the predictor variables (spectra)
can be summarized into a few PLS factors. Decomposi-
tion of the PLS factors, using the loading vectors, can
identify which variables had the most weight in the pre-
dictive PLSR model. A 10-fold cross-validation, which is
a common statistical analysis technique for estimating
model performance, was performed on the data set to
evaluate the performance of the predictive model. Cross-
validation is a standard multivariate statistical technique
often used on small data sets to assess model stability and
determine how well it will perform on future data sets
Figure 1. Peripheral artery disease (PAD) muscle displays abnormal muscle morphometry compared to controls (Cluff et al. 2013; Koutakis
et al., 2015b). Myofibers were selected for microspectral analysis based on a visual inspection of myofibers with abnormal morphometry.
(A) Healthy (control) muscle morphometry typically has polygonal shaped myofibers which are uniform in size and shape, and have a thin
endomysium and perimysium. (B) Muscle tissue from a claudicating PAD patient, and (C) muscle tissue from a PAD patient with critical limb
ischemia (CLI). PAD muscle displays muscle degeneration with increased variation in size and shape, atrophy and enlargement, round and
angular myofibers, and thicker interstitial tissue.
2017 | Vol. 5 | Iss. 5 | e13161
Page 4
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
FTIR Spectral Analysis of PAD Muscle R. A. Becker et al.
(Hastie et al. 2009). The cross-validation technique
rotates the membership of the samples (during calibra-
tion) to ensure that the results are not membership
dependent (i.e., calibration group and validation group)
and to ensure that the model is not overfitting the data.
Results
Figure 2A presents the raw ATR-FTIR spectra obtained
from the muscle samples (i.e., 10 spectra per sample
resulting in a total of 130 spectra). The baseline correc-
tion algorithm estimated baseline regression points
(Fig. 2B) and subtracted the fitted multipolynomial curve
to remove intrinsic autofluorescence background signals
and improve signal-to-noise ratios (Lieber and Mahade-
van-Jansen 2003; Afseth et al. 2006; Zhao et al. 2007;
Beier and Berger 2009). Figure 2C presents four major
absorption regions that were investigated: Window 1
(W1) 900–1200 cm1 (oligosaccharides and phosphate
group region), Window 2 (W2) 1200–1500 cm1 (mixed
region of fatty acids, proteins, nucleic acids, and
phosphate groups), Window 3 (W3) 1500–1700 cm1
(protein/peptide region), and Window 4 (W4) 2800–
3000 cm1 (fatty acid region) (Payne and Veis 1988;
Naumann et al. 1991; Wang et al. 1993; Packer 1994;
Rehman and Bonfield 1997; Baranska 2013).
After performing an ANOVA and a Bonferroni adjusted
multiple comparisons analysis on these regions, there were
significant differences (P < 0.05) in wavenumbers 1022
(P = 0.035), 1244 (P = 0.048), 1246 (P = 0.048), 1457
(P = 0.019), 1526 (P = 0.036), 1540 cm1 (P = 0.015)
across controls, claudicating, and CLI PAD muscle. Fig-
ure 3A–D presents notched box-and-whisker plots of four
of these wavenumbers. These differences signify important
changes in the biochemical composition of the muscle cells
as they sustain damage and eventually undergo apoptosis
or necrosis, with concomitant change to the muscle
pathology. While they are not measured with ABI, many
of these changes may be strong candidates as spectral
biomarkers in patients with PAD.
Using the first four PLS factors, the PLSR model was
trained and the predictive performance was evaluated
using a 10-fold cross-validation procedure. The PLSR
model was able to predict patient ABIs with a coefficient
of determination of R2 = 0.85 during cross-validation
(Fig. 4A) and a root mean square error-cross validation
(RMSE-CV) of 0.37. Figure 4B demonstrates that most of
the variance in the data was explained by the first three
to four PLS factors. A 3D plot (Fig. 4C) of the first three
PLS factor scores demonstrate clear separation of the con-
trols, claudicants, and CLI patients. An examination of
the PLS factor weights (Fig. 5) gives an indication of
which wavenumbers had the most important impact on
predicting the patient’s ABIs, thus indicating that these
are key spectral bands.
These key spectral bands may point the way toward
new or neglected therapeutic targets. Accordingly,
wavenumbers 1024, 1089, 1469, 1526, 2850, and
2916 cm1 were the strongest spectral biomarkers for ABI
prediction. It was interesting to note that some of these
key spectral bands in the PLSR multivariate analysis, also
matched some of the bands found to be significant in the
univariate (ANOVA) statistical analysis.
Discussion
In this study, we demonstrated that ATR-FTIR
microspectroscopy can perform detailed and precise mea-
surements of the biochemical changes that occur in the
chronically ischemic muscles of PAD patients. This is the
first study to produce ATR-FTIR profiles of normal and
diseased skeletal muscle and our data demonstrate that
the skeletal muscle is very sensitive to chronic ischemia
and undergoes biochemical changes that correspond to
the degree of hemodynamic compromise and the clinical
severity of PAD.
The ATR-FTIR analysis revealed spectral bands in the
phosphate region (Window 1: 900–1200 cm1) showing a
higher intensity in both claudicating and CLI patients,
signifying an increase in intracellular phosphate with
increasing muscle damage. This may be a critical observa-
tion, considering the importance of phosphate-related
molecules in cellular health and metabolism. The bands
at 1089 and 1469 cm1 are attributed to phosphate-oxy-
gen (P-O) stretching present in sphingosine-1 phosphate,
a biosignaling phospholipid that serves an important role
in muscle regeneration (Garcia-Pacios et al. 2009).
Research has shown that this lipid can activate satellite
cells which can differentiate to increase muscle regenera-
tion (Donati et al. 2013). The increase in the sphin-
gosine-related band suggests that the ischemic myofibers
increase the phosphorylated (activated) sphingosine possi-
bly in an effort to maintain/regenerate the myofibers in
response to damage produced by ischemia in the PAD
limbs (Saiardi 2012; Donati et al. 2013). The increased
phosphate levels could also be due to bone resorption,
which releases both phosphate and calcium into sur-
rounding tissues, and could indicate damaged hormone
regulation pathways. Bone resorption has been shown to
be linked to cardiovascular diseases including PAD,
though there has been little research done on how it
affects muscle damage (Farhat et al. 2007; Farhat and
Cauley 2008; Collins et al. 2009). One of the more inter-
esting observations is that some key signatures (1022,
1024 cm1) in the muscle spectral fingerprints indicate an
increase in glycogen levels (Wood et al. 1996, 1998;
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Movasaghi et al. 2008). It is possible that in the chroni-
cally ischemic state, PAD muscles attempt to compensate
for the blood flow restriction by increasing the resting
glycogen stores in the muscle. This finding is similar to
those of Askew et al. (2005) showing that muscle glyco-
gen content did not differ between PAD subjects and con-
trols. It is possible that the increased glycogen levels are
related to an increase in type II myofibers in the speci-
mens we sampled as Askew et al. (2005) have shown
that glycogen levels are higher in fast versus slow type
myofibers.
The decrease in intensity observed in the mixed region
(Window 2: 1200–1500 cm1) of the PAD spectra com-
pared to the controls may be attributed to a decrease in
deoxyribonucleic acid (DNA) content in the cell. The
bands contributing to wavenumbers 1244 and 1246 cm1
have been attributed to asymmetric phosphate (PO2)
stretching present in DNA (Fabian et al. 1995; Wood
et al. 1996, 1998; Fukuyama et al. 1999; Dovbeshko et al.
2002). Additionally, decreases in the peptide region (Win-
dow 3: 1500-1700 cm1), namely, the band surrounding
1524 cm1 has been found to be related to carbon-
nitrogen (C=N) and carbon-carbon (C=C) stretching pre-
sent in guanine (Fabian et al. 1995; Wood et al. 1998;
Dovbeshko et al. 2000). It is possible that these findings
reflect an overall decrease in DNA level in the cells and
that this is related to damage of nuclear and mitochon-
drial DNA from the chronic ischemic process (Bhat et al.
1999; Pipinos et al. 2006). DNA fragmentation that
occurs during apoptosis or as a result of the increased
oxidative damage seen in PAD muscle may be contribut-
ing to this finding (Pipinos et al. 2008; Weiss et al. 2013;
Koutakis et al. 2014). Furthermore, significant damage to
the mitochondria and their DNA has been previously
shown in PAD (Ryan et al. 2015), and may be the reason
behind the damage to DNA, which appears to be present
in the ATR-FTIR spectra (Makris et al. 2007; Pipinos
et al. 2007; Koutakis et al., 2015a; Thompson et al. 2015).
The band occurring at 1457 cm1 is attributed to
bending of protein methyl groups, and the band occur-
ring at 1540 cm1 is considered to be an amide II band
(Gazi et al. 2003; Fujioka et al. 2004), both of which indi-
cate a decrease in intracellular protein content in the
PAD spectra compared to the controls. Research from
A B
C
W1
W2
W3
W4
Figure 2. (A) All raw ATR-FTIR Spectra collected from Peripheral artery disease (PAD) patients and controls. (B) Spectral data preprocessing
included baseline correction using a fourth degree fitted polynomial and normalization. (C) Average control, claudicating, and critical limb
ischemia (CLI) spectral signatures; Windows, W1: phosphate & oligosaccharide region (900–1200 cm1), W2: mixed region (1200–1500 cm1),
W3: protein/peptide region (1500–1700 cm1), W4: fatty acid region (2800–3000 cm1).
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our group has shown significant damage to the proteins
of the myofibers including proteins that form the
cytoskeleton of the fiber (Koutakis et al., 2015a; Thomp-
son et al. 2015). Our research has also shown that
decreased protein concentration (normalized to muscle
wet weight) in the calves of PAD patients is associated
with worsening myopathy and most importantly predicts
a significant decrease in 5-year mortality rate of the
patient (Thompson et al. 2015). Our current findings are
also in agreement with work from other groups showing
that muscle injury results in leakage of myofiber proteins
with increases in the levels of several different muscle
proteins in the serum, and their detection is one of the
primary laboratory methods used for the identification
and diagnosis of muscle damage in hospitalized patients
(Brancaccio et al. 2010). Creatine kinase (CK) is one of
the proteins easily detected in association with muscle
injury (Baird et al. 2012) while other muscle proteins
constituting some of the most essential structures of the
muscle cell, including actin and myosin are also detected
in the serum of patients having different types of muscle
damage (McKune et al. 2014).
Further investigation of the spectra reveals a marked
decrease in intensities of overall lipids in the fatty acid
region (Window 4: 2800–3000 cm1) in PAD muscle
compared to controls. The bands occurring at 2850 cm1
and 2916 cm1 have been attributed to cholesterol and
creatine, which had lower intensity peaks in PAD muscle
(Dovbeshko et al. 2000). It is known that creatine kinase
levels are increased in the blood, a result of leakage from
damaged muscle cells (Totsuka et al. 2002; Friedman
et al. 2003; Baird et al. 2012). The function of CK is to
regulate the ratio of creatine: phosphocreatine to provide
an acute supply of phosphate for use in ATP synthesis for
cell energetics. CK, creatine, phosphocreatine, and AMPK
have been shown to be involved in complex interactive
regulatory processes (Ponticos et al. 1998). Thus, a reduc-
tion in creatine levels could have profound effects on
AMPK and CK activity and the mechanisms they regulate,
such as glucose uptake and ATP synthesis. The differences
in this region could also be an indicator for lipid peroxi-
dation changes of membrane lipids. The peroxidation of
phospholipids could play an integral role in the total lipid
decrease in muscle tissue. Many phospholipids, when
cleaved, produce fatty acids such as arachidonic acid.
Arachidonic acid causes inflammation, which is increased
in damaged muscle tissue. Sphingosine is also a compo-
nent of many phospholipids; cleavage of these phospho-
lipids would aid in the synthesis of sphingosine-1
phosphate, which would ultimately help regenerate lost
muscle tissue. The decrease of intramyocellular lipid
(INML) content could also be a result of muscle damage.
Little research has been done on INML in damaged PAD
muscle, but the well-described lipid peroxidation occur-
ring within the myofibers can not only cause oxidation of
these lipids but also initiate pathways that will lead to
A B
C D
* *
**
Figure 3. (A–D) Notched box-and-whisker plots representing four significant peaks (P < 0.05) identified by the ANOVA between control
(CON), claudicating (CLAUD), and critical limb ischemia (CLI) Peripheral artery disease (PAD) patients, followed by a Bonferroni adjusted multiple
comparisons analysis indicating which groups were significantly different. In the box-and-whisker plot, the center line indicates the median,
while the top and bottom of each box represents the 75th and 25th percentiles, respectively. The notches represent the 95% confidence
interval around each median, and the upper and lower whiskers indicate the maximum and minimum values, respectively.
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Figure 4. (A) The partial least squares regression (PLSR) model was able to predict patient ABIs with an R2=0.85 using the first four PLS factors
and a 10-fold cross validation (B) The first 3-4 PLS factors explained most of the variance in the data set. (C) A 3D plot of the first 3 PLS
factors demonstrates clear separation between controls, claudicating, and CLI patients based on the spectral profiles of the muscle
biochemistry.
Figure 5. The weight of each PLS-factor indicates which wavenumbers had the most influence on the partial least squares regression (PLSR)
predictive model. This was used to identify important bands and focus the interpretation of the spectral signatures to potential biochemical
change.
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export of the oxidized lipid domains and lipid fragments
from the cell (Schrauwen-Hinderling et al. 2003, 2006;
Powers and Jackson 2008). Furthermore, little research
has been done on the concentrations and activity of per-
oxidative enzymes such as those of the peroxisomes dur-
ing chronic muscle injury. These could be the key
components in the regulation of lipid bilayer homeostasis
in ischemic conditions and warrant further research into
the role they play in PAD.
While ATR-FTIR provides broad reaching and informa-
tion-rich spectral profiles of the muscle biochemistry limi-
tations of this study include the small patient sample size
and that the interpretation of the spectral peaks can be
complicated. Additionally, although the myofibers were
selected based on visual inspection to obtain spectra from,
there is the possibility that the results may not be repre-
sentative of the entire muscle sample due to the small
sample size of myofibers measured. Interpreting the spec-
tral profile is complicated because the optical spectral sig-
nals are frequently the aggregate of signals from many
biomolecules present in the muscle samples. Further, the
spectral peaks that were identified and discussed in this
study warrant further study to provide supporting bio-
chemical analysis to validate these potential targets. As the
experience of our team and others increases with the
specificity and analysis of each one of the windows and
bands of ATR-FTIR, we will be able to provide detailed
dissections of the biochemical effects of PAD on human
myofibers. While many of these effects and mechanisms
have been highlighted, more research is needed to further
elucidate the fundamental causes of ischemia-induced
muscle degeneration, and to accurately grade it both for
the purposes of measuring the degree of myopathy in the
PAD leg and for using it as a method to follow the
responses of the muscle to different treatment methods.
Further work from our group endeavors to produce chem-
ical maps for entire cross sections of PAD muscle. By
mapping spectral signals from the entire cross section of a
myofiber, more insight could be obtained from the peaks
that were identified in this study. ATR-FTIR may be a
powerful bioanalytical technique to provide critical insight
into potential spectral biomarkers for muscle damage and
how it affects the tissues at a molecular level. Muscle cell
physiology is an expression of numerous complex mecha-
nisms, many still unknown, that could be used to develop
new therapies or tests for early diagnosis and more effec-
tive treatment for PAD-induced muscle damage.
Significance and Conclusions
ATR-FTIR spectroscopy was able to characterize the
effects of PAD on the gastrocnemius muscle by identify-
ing the unique biochemical signatures of the affected
myofibers. The identified signatures can discriminate con-
trol spectra from PAD muscle tissue and correlate with
the clinical presentation of PAD patients. While the spec-
tra do not immediately reveal mechanisms operating to
connect the arterial occlusive disease with the myopathy
of PAD, they point into areas of research that need to be
explored, and play an integral role in developing methods
for discovering new therapeutic targets for treating the
muscle damage in the legs of PAD patients. This work
may also identify novel spectral biomarkers that can com-
plement the currently available methods for the diagnosis
of the degree of myopathy and for monitoring the way
the myopathy responds to established and new therapies
for PAD patients.
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